NORTH AMERICA AND EUROPE AGE RELATED MACULAR DEGENERATION THERAPEUTICS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Table of Contents (Version-2026)

1. Research Objectives and Assumptions

   • Research Objectives
   • Assumptions
   • Abbreviations

2. Market Purview

   • Report Description
     • Market Definition and Scope
   • Executive Summary
     • Market Snapshot, By Disease Type
     • Market Snapshot, By Drug Type
     • Market Snapshot, By Distribution Channel
     • Market Snapshot, By Region
   • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

   • Market Dynamics
     • Drivers
     • Restraints
     • Market Opportunities
   • Impact Analysis
   • Recent Product Launches
   • Epidemiology
   • Merger, Acquisition, and Collaborations
   • Regulatory Scenario
   • Key Developments
   • PEST Analysis

4. North America & Europe Age-related Macular Degeneration Therapeutics Market, By Disease Type, 2021–2033, (US$ Billion)

   • Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2022–2033
     • Segment Trends
   • Dry AMD
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
   • Wet AMD
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)

5. North America & Europe Age-related Macular Degeneration Therapeutics Market, By Drug Type, 2021–2033, (US$ Billion)

   • Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2022–2033
     • Segment Trends
   • Aflibercept (Eylea)
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
   • Ranibizumab (Lucentis)
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
   • Bevacizumab (Avastin)
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
   • Pegaptanib (Macugen)
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
   • Verteporfin (Visudyne)
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
   • Brolucizumab (Beovu)
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
   • Supplements
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
   • Others
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)

6. North America & Europe Age-related Macular Degeneration Therapeutics Market, By Distribution Channel, 2021–2033, (US$ Billion)

   • Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2022–2033
     • Segment Trends
   • Hospital Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
   • Retail Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
   • Online Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)

7. North America & Europe Age-related Macular Degeneration Therapeutics Market, By Region, 2021–2033, (US$ Billion)

   • Introduction
     • Market Share Analysis, By Region, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, For Region, 2022–2033
     • Regional Trends
   • North America
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Disease type, 2021 - 2033, (US$ Billion)
     • Market Size and Forecast, and Y-o-Y Growth, By Drug type, 2021 - 2033, (US$ Billion)
     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Billion)
     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021–2033, (US$ Billion)
       • U.S.
       • Canada
   • Europe
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Disease type, 2021 - 2033, (US$ Billion)
     • Market Size and Forecast, and Y-o-Y Growth, By Drug type, 2021 - 2033, (US$ Billion)
     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Billion)
     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021–2033, (US$ Billion)
       • U.K.
       • Germany
       • Italy
       • France
       • Spain
       • Russia
       • Rest of Europe

8. Competitive Landscape

   • Novartis AG
     • Company Highlights
     • Product Portfolio
     • Key Highlights
     • Financial Performance
     • Market Strategies
   • Bayer AG
     • Company Highlights
     • Product Portfolio
     • Key Highlights
     • Financial Performance
     • Market Strategies
   • Bausch Health Companies Inc.
     • Company Highlights
     • Product Portfolio
     • Key Highlights
     • Financial Performance
     • Market Strategies
   • Regeneron Pharmaceuticals, Inc
     • Company Highlights
     • Product Portfolio
     • Key Highlights
     • Financial Performance
     • Market Strategies
   • F.Hoffmann-La Roche AG
     • Company Highlights
     • Product Portfolio
     • Key Highlights
     • Financial Performance
     • Market Strategies
   • Pfizer, Inc.
     • Company Highlights
     • Product Portfolio
     • Key Highlights
     • Financial Performance
     • Market Strategies
   • Valeant Pharmaceuticals International, Inc.
     • Company Highlights
     • Product Portfolio
     • Key Highlights
     • Financial Performance
     • Market Strategies
   • AbbVie Inc.
     • Company Highlights
     • Product Portfolio
     • Key Highlights
     • Financial Performance
     • Market Strategies
   • Viatris Inc.
     • Company Highlights
     • Product Portfolio
     • Key Highlights
     • Financial Performance
     • Market Strategies
   • Amgen Inc.
     • Company Highlights
     • Product Portfolio
     • Key Highlights
     • Financial Performance
     • Market Strategies

9. Section

   • Research Methodology
   • About Us

*Browse 38 market data tables and 35 figures on “Age-related Macular Degeneration Therapeutics Market”- North America & Europe forecast to 2033